Safety, tolerability and preliminary efficacy of poziotinib with twice daily strategy in EGFR/HER2 Exon 20 mutant non-small cell lung cancer Meeting Abstract

International Collaboration

cited authors

  • Sacher, A.; Le, X.; Cornelissen, R.; Shum, E.; Suga, J.; Socinski, M.; Molina, J. R.; Haura, E.; Clarke, J.; Bhat, G.; Lebel, F.; Garassino, M. C.

authors

Publication Date

  • March 1, 2021

webpage

published in

category

start page

  • S15

end page

  • S15

volume

  • 32